Official Louisiana Legislative Bureau Digest — AI analysis is being generated. The official digest is shown below in the meantime.
SB 169 Original 2026 Regular Session Talbot
Present law requires coverage for biomarker testing when clinical utility is demonstrated.
Proposed law retains present law.
Proposed law clarifies how clinical utility is established.
Proposed law prohibits conditioning coverage on laboratory classifications or credentialing standards unrelated to the performance of the covered test.
Proposed law resolves any inconsistencies between present law relative to coverage for genetic testing to screen for cancer and present law relative to biomarker testing of existing conditions.
Effective upon signature of the governor or lapse of time for gubernatorial action.
(Amends R.S. 22:1028.5(D); adds R.S. 22:1028.5(B)(4) and (F))